Texas Yale Capital Corp. cut its stake in HCP, Inc. (NYSE:HCP) by 50.0% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 14,580 shares of the real estate investment trust’s stock after selling 14,580 shares during the quarter. Texas Yale Capital Corp.’s holdings in HCP were worth $466,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently modified their holdings of HCP. BlackRock Inc. increased its stake in shares of HCP by 1.3% during the first quarter. BlackRock Inc. now owns 46,737,345 shares of the real estate investment trust’s stock valued at $1,462,881,000 after purchasing an additional 591,173 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of HCP by 5.4% during the first quarter. JPMorgan Chase & Co. now owns 11,420,161 shares of the real estate investment trust’s stock valued at $357,451,000 after purchasing an additional 581,291 shares in the last quarter. Resolution Capital Ltd increased its stake in shares of HCP by 18.9% during the second quarter. Resolution Capital Ltd now owns 8,757,892 shares of the real estate investment trust’s stock valued at $280,077,000 after purchasing an additional 1,393,502 shares in the last quarter. Northern Trust Corp increased its stake in shares of HCP by 8.8% during the first quarter. Northern Trust Corp now owns 8,540,565 shares of the real estate investment trust’s stock valued at $267,320,000 after purchasing an additional 688,358 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in shares of HCP by 11.8% during the fourth quarter. Geode Capital Management LLC now owns 7,752,843 shares of the real estate investment trust’s stock valued at $216,236,000 after purchasing an additional 821,285 shares in the last quarter. Institutional investors and hedge funds own 95.65% of the company’s stock.
HCP has been the subject of a number of analyst reports. KeyCorp raised their target price on shares of HCP from $32.00 to $34.00 and gave the company an “overweight” rating in a research note on Monday, July 1st. Raymond James raised shares of HCP from a “market perform” rating to an “outperform” rating and set a $35.00 target price for the company in a research note on Thursday, June 13th. TheStreet raised shares of HCP from a “c+” rating to a “b-” rating in a research note on Friday, August 2nd. Finally, Stifel Nicolaus raised their target price on shares of HCP from $32.00 to $34.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. Three research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $31.30.
Shares of HCP traded up $0.10 on Thursday, hitting $33.81. 485,039 shares of the stock traded hands, compared to its average volume of 2,251,919. The stock has a market cap of $15.94 billion, a P/E ratio of 18.58, a PEG ratio of 7.01 and a beta of 0.31. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.90 and a quick ratio of 0.90. The firm has a 50 day simple moving average of $32.40. HCP, Inc. has a one year low of $24.47 and a one year high of $34.00.
HCP (NYSE:HCP) last announced its quarterly earnings results on Wednesday, July 31st. The real estate investment trust reported ($0.03) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by ($0.46). The firm had revenue of $489.15 million for the quarter, compared to the consensus estimate of $444.67 million. HCP had a net margin of 53.57% and a return on equity of 15.54%. HCP’s revenue was up 4.5% on a year-over-year basis. During the same period last year, the business earned $0.45 EPS. On average, equities research analysts forecast that HCP, Inc. will post 1.75 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, August 20th. Investors of record on Monday, August 5th will be given a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a dividend yield of 4.38%. The ex-dividend date of this dividend is Friday, August 2nd. HCP’s dividend payout ratio (DPR) is currently 81.32%.
HCP Company Profile
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Featured Story: Dead Cat Bounce
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.